Sulfonylurea

Data from this study shows the effects of oral diabetes medications on HbA1C levels from two separate cohort groups.

Cardiovascular risks in patients with type 2 diabetes using sulfonylureas vs. pioglitazone: personalized care approach.

Which baseline clinical characteristics of patients with newly diagnosed diabetes lead us to providing more personalized care?

Drugs shown to increase risk of hypoglycemic and cardiovascular events.

Even as 2nd-line drugs, sulfonylureas shown to be cardiotoxic with high rate of low blood glucose

Cheapest treatment associated with increased risks of cardiovascular events and death.

Improvements seen in children with developmental delays associated with neonatal diabetes.

Study adds further evidence to the proposed causal relationship between sulfonylureas and adverse cardiovascular events.

Higher cumulative doses and duration of glyburide may be associated with increased risk...

Incidence of type 2 diabetes is increasing rapidly. It accounts for up to half of all cases of new-onset diabetes in young people. Dysfunction in glucose homeostasis impacts acid-base regulation. In addition, injury to organs as a result of diabetes and antidiabetic drugs contribute to this dysregulation. Hyponatremia is associated …